Compare WKSP & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WKSP | ENVB |
|---|---|---|
| Founded | 2003 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0M | 8.1M |
| IPO Year | 2015 | 2000 |
| Metric | WKSP | ENVB |
|---|---|---|
| Price | $0.44 | $1.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.25 | N/A |
| AVG Volume (30 Days) | ★ 6.9M | 67.8K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.89 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $16,101,738.00 | ★ $39,914,675.00 |
| Revenue This Year | $131.96 | N/A |
| Revenue Next Year | $24.81 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 89.78 | N/A |
| 52 Week Low | $0.37 | $0.57 |
| 52 Week High | $3.90 | $13.25 |
| Indicator | WKSP | ENVB |
|---|---|---|
| Relative Strength Index (RSI) | 33.45 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $0.77 | N/A |
| Average True Range (ATR) | 0.04 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 26.81 | 0.00 |
Worksport Ltd designs, develops, and manufactures products for markets including automotive accessories, consumer electronics, and residential and commercial HVAC systems. The company leverages a growing intellectual property portfolio of patents, designs, and trademarks covering products such as tonneau covers, solar-integrated tonneau covers, portable power stations, hydrogen-based green energy systems, heat pumps, and EV charging solutions. Its segments include soft tonneau covers, consisting mainly of vinyl-wrapped tri-fold and quad-fold covers manufactured by third-party suppliers, and hard tonneau covers, which generate the majority of revenue in the United States and include aluminum tri-fold and quad-fold covers manufactured and assembled in the United States.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.